Attend this webinar to hear my PhUSE Keynote from Hyderabad, India in July.
What starts as initial positive results from breakthrough therapies can blossom into a multi-center, international phase three clinical study over several years. Throughout the history of FDA and other federal health protection agencies, the mission has always been to expect high quality data and efficient review process. As we serve this industry either as pharmaceutical companies or CROs, our objectives are common. From start to finish, the journey that programmers and statisticians take should be guided with CDISC compliance, better use of programming techniques and technology, and high motivation to overcome data and analysis challenges to produce efficacy results that significantly improve patient outcome while reducing the risks.
SAS Savvy Premium/University Members attend for free but still need to register. Non SAS Savvy Premium Members must pay $65. It's not too late to upgrade today to attend for free.
Computer and phone connections are required. Webinar will be recorded for on-demand viewin
© 2023 Sunil Gupta, SAS Savvy, All Rights Reserved, Sunil@SASSavvy.com, SAS is a registered trademark of SAS Institute Inc.
SAS, Statistical Analysis System, and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ® indicates USA registration.